EMBC EMBECTA CORP

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2023 at 9:45 a.m. PT / 12:45 p.m. ET.

Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at .

About embecta 

embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit .

CONTACTS 

 

Investors:

Pravesh Khandelwal

VP, Head of Investor Relations

551-264-6547 

Media:

Christian Glazar

Sr. Director, Corporate Communications 

908-821-6922 

 



EN
14/12/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EMBECTA CORP

 PRESS RELEASE

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025. "Q3 was a strong quarter for embecta, reflecting solid commercial execution, aided in part by the timing of customer orders. Despite an increasingly complex and dynamic geopolitical environment, given the year-to-date performance and our outlook for the remainder of the year, we are ti...

 PRESS RELEASE

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on September 15, 2025 to stockholders of record at the close of business on August 29, 2025. About embecta embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innova...

 PRESS RELEASE

embecta to Report Fiscal Third Quarter 2025 Financial Results

embecta to Report Fiscal Third Quarter 2025 Financial Results PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 8, 2025. Those who would like to participate may access the live webcast , or access the teleconference ....

 PRESS RELEASE

embecta to Participate in Investor Events

embecta to Participate in Investor Events PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events: 2025 Goldman Sachs Tenth Annual Leveraged Finance and Credit Conference Management will host one-on-one investor meetings on Thursday, May 29, 2025, at Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA. 2025 Jefferies Global Healthcare Con...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch